Girona FC has renewed its agreement with Brill Pharma, the pharmaceutical company responsible for distributing the HYLO® range in Spain, belonging to the prestigious German group Ursapharm, for another three seasons. The HYLO® brand will remain on the sleeve of the game shirt in a historic campaign for the Club, which will compete in the Champions League. This milestone not only underlines the level of sporting success achieved by Girona FC, but also provides an unparalleled platform for promoting HYLO® and Brill Pharma on an international level.
This strategic partnership will not only bring significant benefits to the Club, but will also increase the visibility of the HYLO® and Brill Pharma brand in the dynamic world of football and among Girona FC’s passionate fans.
The renewal of this agreement reaffirms Girona FC’s commitment to excellence and its willingness to collaborate with market-leading brands. HYLO®, recognized for its effectiveness in ophthalmological care, has established itself as a reference in dry eyes in Spain, and this strategic alliance will further strengthen its presence in the sports sector.
The partnership between Girona FC and Brill Pharma is a clear demonstration of their mutual commitment to excellence and innovation. We are confident that this collaboration will continue to be fruitful and beneficial for both parties, contributing to the success of the Club and the growth of the HYLO® brand in the market.
About Brill Pharma
Brill Pharma is a leading Spanish pharmaceutical company specializing in ophthalmic products. As the exclusive distributor of the HYLO® line in Spain, Brill Pharma is dedicated to providing innovative and effective vision care solutions.
About HYLO®
HYLO® is the leading dry eye treatment brand, offering high-quality products that soothe and protect dry eyes. Owned by the German group Ursapharm, HYLO® has established itself as a market leader thanks to its effectiveness and safety.
